Danil V Makarov

Summary

Affiliation: Yale University
Country: USA

Publications

  1. doi Regional variation in total cost per radical prostatectomy in the healthcare cost and utilization project nationwide inpatient sample database
    Danil V Makarov
    Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    J Urol 183:1504-9. 2010
  2. doi Patterns of care and outcomes associated with intensity-modulated radiation therapy versus conventional radiation therapy for older patients with head-and-neck cancer
    James B Yu
    Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT, USA
    Int J Radiat Oncol Biol Phys 83:e101-7. 2012
  3. doi The population level prevalence and correlates of appropriate and inappropriate imaging to stage incident prostate cancer in the medicare population
    Danil V Makarov
    Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine, New Haven, United States
    J Urol 187:97-102. 2012
  4. doi Immortal time bias: a frequently unrecognized threat to validity in the evaluation of postoperative radiotherapy
    Henry S Park
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT, USA
    Int J Radiat Oncol Biol Phys 83:1365-73. 2012
  5. doi The association between diffusion of the surgical robot and radical prostatectomy rates
    Danil V Makarov
    Robert Wood Johnson Foundation Clinical Scholars Program, Yale University School of Medicine, New Haven, CT, USA
    Med Care 49:333-9. 2011
  6. doi A new formula for prostate cancer lymph node risk
    James B Yu
    Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT 06520, USA
    Int J Radiat Oncol Biol Phys 80:69-75. 2011
  7. pmc The cost implications of prostate cancer screening in the Medicare population
    Xiaomei Ma
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut Cancer Outcomes, Public Policy and Effectiveness Research Center, Yale University, New Haven, Connecticut
    Cancer 120:96-102. 2014
  8. ncbi Determinants of enrollment in cancer clinical trials: the relationship between the current state of knowledge, societal disease burden, and randomized clinical trial enrollment
    Shane Lloyd
    From the aDepartment of Therapeutic Radiology, Yale School of Medicine, New Haven, Connecticut bMemorial Sloan Kettering Cancer Center, New York, New York cDepartment of Internal Medicine, Yale School of Medicine, New Haven, Connecticut and dUnited States Department of Veterans Affairs, New York University School of Medicine, Departments of Urology, Population Health and Cancer, New York, New York
    J Natl Compr Canc Netw 11:928-36. 2013
  9. doi Renal ultrasonography in the evaluation of acute kidney injury: developing a risk stratification framework
    Adam Licurse
    Yale University, New Haven, CT 06520 8025, USA
    Arch Intern Med 170:1900-7. 2010
  10. doi Validation of the partin nomogram for prostate cancer in a national sample
    James B Yu
    Department of Therapeutic Radiology, Yale School of Medicine, New Haven, Connecticut, USA
    J Urol 183:105-11. 2010

Detail Information

Publications11

  1. doi Regional variation in total cost per radical prostatectomy in the healthcare cost and utilization project nationwide inpatient sample database
    Danil V Makarov
    Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    J Urol 183:1504-9. 2010
    ..We determined whether state level variation in the cost of radical prostatectomy exists and whether we could explain this variation by adjusting for covariates associated with cost...
  2. doi Patterns of care and outcomes associated with intensity-modulated radiation therapy versus conventional radiation therapy for older patients with head-and-neck cancer
    James B Yu
    Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT, USA
    Int J Radiat Oncol Biol Phys 83:e101-7. 2012
    ..We performed a retrospective cohort study of Medicare patients treated with IMRT compared with standard RT to assess outcomes in national practice...
  3. doi The population level prevalence and correlates of appropriate and inappropriate imaging to stage incident prostate cancer in the medicare population
    Danil V Makarov
    Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine, New Haven, United States
    J Urol 187:97-102. 2012
    ..According to guidelines most men with incident prostate cancer do not require staging imaging. We determined the population level prevalence and correlates of appropriate and inappropriate imaging in this cohort...
  4. doi Immortal time bias: a frequently unrecognized threat to validity in the evaluation of postoperative radiotherapy
    Henry S Park
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT, USA
    Int J Radiat Oncol Biol Phys 83:1365-73. 2012
    ..To evaluate the influence of immortal time bias on observational cohort studies of postoperative radiotherapy (PORT) and the effectiveness of sequential landmark analysis to account for this bias...
  5. doi The association between diffusion of the surgical robot and radical prostatectomy rates
    Danil V Makarov
    Robert Wood Johnson Foundation Clinical Scholars Program, Yale University School of Medicine, New Haven, CT, USA
    Med Care 49:333-9. 2011
    ..Despite its expense and controversy surrounding its benefit, the surgical robot has been widely adopted for the treatment of prostate cancer...
  6. doi A new formula for prostate cancer lymph node risk
    James B Yu
    Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT 06520, USA
    Int J Radiat Oncol Biol Phys 80:69-75. 2011
    ..The Roach formula (RF) has been criticized as overestimating LN risk. A modification of the RF has been attempted by other investigators using simplified adjustment ratios: the Nguyen formula (NF)...
  7. pmc The cost implications of prostate cancer screening in the Medicare population
    Xiaomei Ma
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut Cancer Outcomes, Public Policy and Effectiveness Research Center, Yale University, New Haven, Connecticut
    Cancer 120:96-102. 2014
    ..Recent debate about prostate-specific antigen (PSA)-based testing for prostate cancer screening among older men has rarely considered the cost of screening...
  8. ncbi Determinants of enrollment in cancer clinical trials: the relationship between the current state of knowledge, societal disease burden, and randomized clinical trial enrollment
    Shane Lloyd
    From the aDepartment of Therapeutic Radiology, Yale School of Medicine, New Haven, Connecticut bMemorial Sloan Kettering Cancer Center, New York, New York cDepartment of Internal Medicine, Yale School of Medicine, New Haven, Connecticut and dUnited States Department of Veterans Affairs, New York University School of Medicine, Departments of Urology, Population Health and Cancer, New York, New York
    J Natl Compr Canc Netw 11:928-36. 2013
    ..01) had the strongest association with planned RCT enrollment. Findings showed, therefore, that planned cancer RCT enrollment is associated with higher societal disease burden, not the quality of a cancer's clinical guidelines. ..
  9. doi Renal ultrasonography in the evaluation of acute kidney injury: developing a risk stratification framework
    Adam Licurse
    Yale University, New Haven, CT 06520 8025, USA
    Arch Intern Med 170:1900-7. 2010
    ..In adult inpatients with acute kidney injury (AKI), clinicians routinely order a renal ultrasonography (RUS) study. It is unclear how often this test provides clinically useful information...
  10. doi Validation of the partin nomogram for prostate cancer in a national sample
    James B Yu
    Department of Therapeutic Radiology, Yale School of Medicine, New Haven, Connecticut, USA
    J Urol 183:105-11. 2010
    ..The nomogram is based on patients undergoing radical prostatectomy at The Johns Hopkins Medical Institutions. We validated the Partin tables in a large, population based sample...
  11. pmc Pro-prostate-specific antigen measurements in serum and tissue are associated with treatment necessity among men enrolled in expectant management for prostate cancer
    Danil V Makarov
    Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine, New Haven, Connecticut, USA
    Clin Cancer Res 15:7316-21. 2009
    ....